Following up on an eventful 2016, this year brings plenty of value-creating events for marijuana stocks. Here’s what to look for with Insys Therapeutics (NASDAQ: INSY), GW Pharmaceuticals (NASDAQ: GWPH) and Corbus Pharmaceuticals Holdings (NASDAQ: CRBP).
Continue Reading Below
Image source: Getty Images.
Last July, Insys Therapeutics gained approval from the Food and Drug Administration for Syndros, its pharmaceutical version of tetrahydrocannabinol (THC) — a component of marijuana — that treats anorexia associated with weight loss in AIDS patients and cancer-induced nausea and vomiting. But the company can’t sell the drug yet, because it still needs to wait for the Drug Enforcement Agency to schedule it.